The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy

• Recent studies of the genomic landscape of salivary gland tumors have provided important insights into the molecular pathogenesis of these tumors. The most consistent alterations identified include a translocation-generated gene fusion network involving transcription factors, transcriptional coactivators, tyrosine kinase receptors, and other kinases. In addition, next-generation sequencing studies of a few subtypes of salivary neoplasms have revealed hotspot mutations in individual genes and mutations clustering to specific pathways frequently altered in cancer. Although limited, these studies have opened up new avenues for improved classification and targeted therapies of salivary gland cancers. In this review, we summarize the latest developments in this field, focusing on tumor types for which clinically important molecular data are available.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Chromosome translocations

Gene fusions

Mutation

Biomarker

Salivary gland cancer

Targeted

adenoid cystic carcinoma

nut midline carcinoma

analog secretory

carcinoma

acute lymphoblastic-leukemia

copy number alterations

ex

pleomorphic adenoma

factor-i receptor

duct carcinoma

mucoepidermoid

carcinomas

kinase inhibitor

Oncology

Dentistry

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)